Patents by Inventor Yibing Peng

Yibing Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN ALPHA FETOPROTEIN-SPECIFIC T CELL RECEPTORS AND USES THEREOF
    Publication number: 20220048971
    Abstract: T cell receptors that specifically recognize hAFP158 and methods of their use are provided.
    Type: Application
    Filed: June 21, 2021
    Publication date: February 17, 2022
    Inventors: Yukai He, Wei Zhu, Esteban Celis, Yibing Peng, Lan Wang
  • Human alpha fetoprotein-specific murine T cell receptors and uses thereof
    Patent number: 11041011
    Abstract: T cell receptors that specifically recognize hAFP158 and methods of their use are provided.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: June 22, 2021
    Assignees: Augusta University Research Institute, Inc., National Institutes of Health (NIH), U.S. Dept. of Health And Human Services (DHHS), U.S. Government NIH Division of Extramural Inventionsl and Technology Resources (DEITR)
    Inventors: Yukai He, Wei Zhu, Esteban Celis, Yibing Peng, Lan Wang
  • Human Alpha Fetoprotein-Specific Murine T Cell Receptors and Uses Thereof
    Publication number: 20180327473
    Abstract: T cell receptors that specifically recognize hAFP158 and methods of their use are provided.
    Type: Application
    Filed: May 2, 2018
    Publication date: November 15, 2018
    Inventors: Yukai He, Wei Zhu, Esteban Celis, Yibing Peng, Lan Wang